NCT03932578View on ClinicalTrials.gov

Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 5, 2019

Primary Completion Date

August 28, 2019

Study Completion Date

August 28, 2019

Conditions
NauseaVomiting
Interventions
DRUG

Atropine sulfate

Patients will receive intrathecal 100 μg of a 1 mg/ml preservative-free atropine sulfate solution

DRUG

Metoclopramide

Patients will receive IV metoclopramide 10 mg in 2 ml

Trial Locations (1)

35111

Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03932578 - Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS | Biotech Hunter | Biotech Hunter